When omicron encountered unvaccinated elderly populations, it proved far from harmless.
Mientras el mundo aprendía a convivir con el virus, una nueva subvariante emergió silenciosamente para recordarle a la humanidad que las pandemias no siguen calendarios humanos. Perú, que ya había atravesado tres olas devastadoras, enfrenta en la primavera de 2022 la posibilidad de una cuarta, impulsada por BA.2, una cepa 1.5 veces más contagiosa que el ómicron original, en un país donde menos del 40% de la población ha recibido una tercera dosis. La experiencia de Hong Kong —casi cuatro mil muertos en diez semanas entre ancianos sin vacunar— no es una estadística lejana, sino un espejo que Perú aún puede elegir no repetir.
- BA.2 no es simplemente una versión más del ómicron: porta 27 mutaciones adicionales y penetra las células de forma distinta a todas las cepas anteriores, lo que lo convierte en un adversario biológicamente nuevo.
- Con menos del 40% de peruanos con tercera dosis, los adultos mayores y personas con enfermedades crónicas permanecen expuestos en el momento más peligroso de la campaña de vacunación.
- Hong Kong encendió la alarma global: cuando el ómicron encontró a ancianos sin vacunar, los muertos se multiplicaron por 17.7 en apenas diez semanas, demostrando que la variante no es inofensiva para todos.
- BA.2 ya circula en Perú desde febrero de 2022, pero su comportamiento en una población con alta infección natural y cobertura incompleta de refuerzo sigue siendo una incógnita crítica.
- La ventana para actuar se cierra: una campaña de refuerzo urgente y focalizada en poblaciones vulnerables es la única barrera real entre la situación actual y la saturación del sistema de salud.
A finales de noviembre de 2021, cuando el mundo comenzaba a hablar de endemicidad, Sudáfrica anunció el descubrimiento de ómicron y reinició el reloj de la pandemia. Lo que pocos comprendieron entonces es que ómicron no era un solo virus: BA.1, BA.2 y BA.3 habían emergido simultáneamente de un ancestro común, tan distintos entre sí como lo habían sido alfa, beta y delta. BA.2, con 27 mutaciones adicionales sobre las 39 compartidas por la familia, resultó ser el más contagioso de los tres —1.5 veces más transmisible que BA.1— y penetra las células de manera completamente diferente a todas las cepas anteriores, de forma similar al SARS original de 2004.
Para la mayoría de las personas con inmunidad robusta o dosis de refuerzo, la infección por ómicron significó síntomas leves: dolor de garganta, malestar general, fiebre baja. Pero Hong Kong ofreció una advertencia brutal. Con apenas el 48% de los mayores de 70 años con dos dosis y solo el 25% de los mayores de 80 con una sola, la ciudad pasó de 213 muertes acumuladas el 31 de enero a 3,993 el 13 de marzo: 17.7 veces más fallecidos en diez semanas que en los dos años anteriores de pandemia. La lección fue clara: ómicron no es inofensivo cuando encuentra a ancianos sin vacunar.
Perú detectó BA.2 en febrero de 2022, pero su comportamiento local permanece incierto. La verdadera fragilidad del país no está en la variante sino en su cobertura de refuerzo: menos del 40% de la población ha recibido una tercera dosis. Si BA.2 desencadena una cuarta ola, golpeará con mayor fuerza a adultos mayores y personas con enfermedades crónicas. Acelerar la vacunación en esos grupos no es ya una recomendación médica —es la única decisión que puede cambiar el desenlace.
In late November 2021, just as the world seemed ready to move past the delta variant and declare the pandemic entering an endemic phase, South Africa's health minister announced the discovery of a new coronavirus strain that would reset the entire trajectory of the crisis. The variant, named omicron by the World Health Organization within 36 hours of identification, carried the scientific designation BA.1—a detail that would soon matter far more than anyone initially realized.
Omicron spread with remarkable speed, compared by epidemiologists to measles in its transmissibility. Within weeks it had displaced delta, the variant that had dominated for months. But omicron was not a single virus. Researchers discovered that BA.2 and BA.3 had emerged simultaneously, all three descended from a common ancestor that likely formed around March 2021. Though grouped as a family because they shared 39 foundational mutations, the three variants were as distinct from one another as alpha, beta, gamma, and delta had been from each other. BA.1 carried 20 additional mutations beyond the shared 39; BA.2 carried 27 more; BA.3 carried 13. Most of these mutations clustered in the spike protein—the structure the virus uses to enter cells and the target of vaccine-generated antibodies. The rest scattered throughout the viral genome, potentially affecting how readily the virus spread from person to person.
BA.2 proved significantly more contagious than its sibling. While it produced less viral load in the nasal passages than the original Wuhan strain, it was estimated to be 1.5 times more transmissible than BA.1 omicron itself. The variant also entered cells differently than all previous strains: like the SARS virus that had vanished in 2004, BA.2 penetrated cells completely rather than fusing its membrane with the host cell membrane—a distinction whose practical consequences remained largely unknown.
In countries where omicron became dominant, most infected people with intact immune systems or booster protection experienced mild illness: sore throat, body aches, low fever, general malaise. But Hong Kong offered a cautionary counterpoint. By January 31, 2022, the city had recorded 213 deaths from omicron. By March 13, that number had climbed to 3,993—meaning that in just ten weeks of March alone, Hong Kong suffered 17.7 times more deaths than it had during the entire first two years of the pandemic. The difference lay not in the virus's inherent lethality but in vaccination rates. Only 48 percent of Hong Kong residents over 70 had received two doses by early March; only 25 percent of those over 80 had received even one. When omicron encountered unvaccinated elderly populations, it proved far from harmless.
By mid-March 2022, BA.2 was driving a resurgence across Europe and gaining ground in the United States. Genomic surveillance showed that between March 13 and 19, BA.2 caused 35 percent of American cases, up from 22 percent the previous week. Experts warned that the variant would likely trigger another wave of infections and feared, as had happened with omicron, that hospitals would become overwhelmed.
Peru had detected BA.2 in February 2022, but the variant's behavior in a population with high rates of natural infection and moderate two-dose vaccination coverage remained uncertain. The real vulnerability lay elsewhere: fewer than 40 percent of Peruvians had received a third dose. If BA.2 sparked a fourth wave, it would likely strike hardest at elderly adults and people with chronic illnesses—precisely the populations least protected by incomplete vaccination campaigns. The window to prevent that outcome was narrowing. A focused push to vaccinate vulnerable groups with booster shots became not a recommendation but an urgent necessity.
Citas Notables
If omicron—and apparently BA.2—infects vulnerable people, the virus can be deadly— Analysis based on Hong Kong epidemiological data
La Conversación del Hearth Otra perspectiva de la historia
Why does it matter that BA.2 is 1.5 times more contagious than BA.1 if both are omicron variants?
Because transmissibility compounds. A virus that spreads 50 percent faster reaches more people in the same timeframe, which means more infections, more hospitalizations, more deaths—especially among the unprotected.
You mention Hong Kong's death toll jumped from 213 to 3,993 in ten weeks. That's a staggering acceleration. What changed?
Not the virus. The population. Hong Kong had low booster coverage and very low vaccination rates among the elderly. When BA.2 hit an unvaccinated elderly population, it killed at rates the city hadn't seen in two years of pandemic.
So Peru's situation is similar—low booster coverage below 40 percent. Does that mean Peru faces the same outcome?
It means Peru faces the same risk. But risk is not destiny. Hong Kong didn't prioritize vaccination. Peru still had time to change course, to target the elderly and immunocompromised with boosters before BA.2 became dominant.
The article mentions BA.2 enters cells differently than previous variants. Does that make it more dangerous?
It makes it different in ways we didn't fully understand yet. It enters completely, like SARS did, rather than fusing membranes. Whether that matters clinically—whether it changes severity or immune evasion—was still an open question in March 2022.
If most infected people with boosters get mild illness, why the alarm?
Because "most" is not "all." And the unvaccinated elderly aren't part of that "most." One person's mild case is another person's death. The alarm is for the people who fall through the cracks.